MEMBER LOGIN


ASSOCIATED TECHNOLOGY PARTNERS

 

Agilent Technologies

5301 Stevens Creek Blvd, Santa Clara CA 95051, United States

Represented by: Mark Vossenaar, Sr. Director Strategic Marketing Life Sciences Group, Neil Cook, Vice President.

 

General Electric Healthcare

Chalfont St. Giles (United Kingdom)

Represented by: Dr. Ian Wilson, Head of Biology GE Healthcare's Medical Diagnostics Division, Robert Dann, Oncology Marketing Leader, MI/PET.

 

Life Technologies Corporation

Foster City, United States

Represented by: Martin Naley, Kimberlee Caple, Herve Pouzoullic, and Simone Guenther.

NON-PROFIT ORGANISATIONS

 

National Breast Cancer Foundation

Inc., 2600 Network Blvd., Ste. 300, Frisco, TX 75034

Represented by: Janelle Hail, CEO and Co-founder

 

Sage Bionetworks

1100 Fairview Ave., N. Mailstop M1-C108, Seattle, WA 98109, United States

Represented by: Jonathon G. Izant PhD Vice-President, Stephen Friend, President.

ACADEMIC INSTITUTIONS

 

Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)

Tata Memorial Centre, Kharghar, Navi Mumbai, 410210, India

Represented by: Dr. Rita Mulherkar, Ph.D.

 

Ben-Gurion University of the Negev

Beer Sheva, 84105, Israel

Represented by: Prof Angel Porgador

 

Fondazione IRCCS Istituto Nazionale dei Tumori

Via Venezian, 1, 20133 Milano, Italy

Represented by: Dr. Marco A. Pierotti, Scientific Director

 

Fudan University Shanghai Cancer Center

270 Dong An Road, Shanghai, 200032, China

Represented by: Guoliang Jiang, President and Dr. Dingwei Ye, Vice President International Affairs.

 

FundaçaoPio XII – Hospital de Câncer de Barretos – Pius XII Foundation

Av. Antenor Duarte Villela, 1331-Barretos Sao Paulo, 1478-400, Brazil

Represented by: André Lopes Carvalho, Scientific Director, and Edmundo Carvalho Mauad, Representative of the Board of Directors.

 

Fundació Privada Institut d'Investigació Oncològica de Vall Hebron (VHIO)

Passeig Vall Hebron, 119, Edifici Maternoinfantil, planta 14, 08035 Barcelona, Spain

Represented by: Dr Andres de Kelety, Managing Director of VHIO.

 

Hadassah University Medical Center

Ein-Kerem, Jerusalem 92000, Israel

Represented by: Prof. Tamar Peretz M.D., PhD and Dr. Asher Y. Salmon M.D.

 

Institut de Cancérologie Gustave Roussy

114 Rue Edouard Vaillant, 94805, Villejuif France

Represented by: Prof. Alexander Eggermont, General Director, Prof. Thomas Tursz, Vice President of WIN consortium, Prof. Gilles Vassal and Dr. Vladimir Lazar, Chief Operating Officer of WIN consortium.

 

Institute for Digestive Diseases and Liver Transplantation Bucharest Romania (ICBDTHF)

258 Fundeni Street, Sector 2, 022328, Bucharest Romania

Represented by: Prof. Irinel Popescu (Director) and Dr. Simona Dima, M.D.; Scientific Director.

 

King Hussein Cancer Center

P.O. Box 1269 Al-Jubeiha, Amman 11941 Jordan

Represented by: Dr. Hikmat Abdel-Razeq, MD, Chairman, Department of Internal Medicine and Dr. Amal Al Omari, PhD, Clinical Research Consultant.

 

National Cancer Centre Singapore

11 Hospital Drive, Singapore 169610

Represented by: Prof Khee Chee Soo, Director

 

Segal Cancer Centre, Jewish General Hospital, McGill University

Canada

Represented by: Dr. Gerald Batist, Professor & Chair, Department of Oncology, McGill; Director, Segal Cancer Centre and Dr. Alan Spatz, Professor of Pathology & Oncology, McGill University; Director of Pathology, Jewish General Hospital.

 

Semmelweis University, Faculty of Medicine

1st Department of Pathology and Experimental Cancer Research, Üllöi Ut 26, H-1085, Budapest, Hungary

Represented by: Prof Andras Matolcsy, MD, PhD, DSc, Dr. Zsofia Balogh, PhD, and Prof. Laszlo Kopper, MD, PhD, DSc.

 

The Chaim Sheba Medical Center

Tel Hashomer 52621, Israel

Represented by: Dr Amir Onn, Scientific Director.

 

The Oncology Institute Ion Chiricuta (IOCN)

34-36 Republici Street, Cluj-Napoca, Romania

Represented by: Pr Alexandru Irimie, Managing Director of IOCN.

 

The University of Medecine and Pharmacy Iuliu Hatieganu

8 Victor Babes street, Cluj-Napoca Romania

Represented by: Pr. Constantin Ciuce, Rector of the University.

 

The University of Texas MD Anderson Cancer Center

1515 Holcombe Boulevard, Unit 91, Houston, Texas 77030-4009, United States

Represented by: Pr. Ronald A. DePinho, M.D., President, Dr. Stanley R. Hamilton M.D., Professor and Division Head, Pathology and Dr. Ignacio Ivan Wistuba M.D., Professor, Pathology Research